Month: July 2021

While diversification and asset allocation can improve returns, systematic and unsystematic risks are inherent in investing. However, along with the efficient frontier, statistical measures and methods, including value at risk (VaR) and capital asset pricing model (CAPM) are useful ways to measure risk. Understanding these tools can help an investor differentiate high-risk investments from stable
0 Comments
Mary Erdoes Adam Galica | CNBC JPMorgan Chase wants to take the sustainable-investing trend to the next level. To do that, the biggest U.S. bank by assets has agreed to buy OpenInvest, a San Francisco-based start-up backed by Andreessen Horowitz and founded by former Bridgewater Associates employees, CNBC has learned exclusively. It’s the third acquisition
0 Comments
Castor Maritime (NASDAQ:CTRM) is a shipping company listed on Nasdaq but which has one employee, Mr. Petros Panagiotidis, located in Cyprus. He is the CEO, CFO, and controlling shareholder of CTRM stock. Recently, some have called into question the one-sided benefits that he is reaping from capital raises. Source: VladSV / Shutterstock.com According to a recent
0 Comments
Mid-cap stocks are often overlooked. However, there are terrific dividend stocks in the mid-cap group that we think are worthy of consideration for income investors. In the world of investing, many investors focus on the biggest stocks in the market – so-called large caps – for their stability and predictability. This makes large-cap stocks generally
0 Comments
From a fundamentals perspective, Clover Health (NASDAQ:CLOV) certainly doesn’t look strong. In fact, there are several indications that the CLOV stock share price should trend downward. However, there are other forces at play here which are keeping prices above where they might otherwise be.  Source: Shutterstock Namely, there is currently a massive amount of short
0 Comments
Before Warren Buffett and Charlie Munger became known as iconic business partners, steering the Berkshire Hathaway empire, they were just two guys from Omaha, Nebraska, who, apparently, were a lot a like. They discovered that thanks to a well-known doctor in town, Dr. Edwin Davis, who told Buffett in a 1957 meeting he trusted him
0 Comments
Current investment into MindMed (NASDAQ:MNMD) stock is very clearly one thing: speculation. Source: Lightspring / Shutterstock.com I don’t say that to disparage individuals from establishing a position in shares of the psychedelics company. Rather, I say it to remind investors that there is really no way to know where it’s going at this point. The development
0 Comments
The last time I wrote about C3.ai (NYSE:AI) was on June 14, two days before the provider of enterprise-scale artificial intelligence (AI) application solutions announced a new partnership with a subsidiary of Singapore Telecommunications (OTCMKTS:SGAPY). Since the announcement, AI stock has moved almost 7% higher.  Source: shutterstock I’m on record stating that if you can
0 Comments